Companies: 10,795·Total market cap: $144.5T
Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

AGIONASDAQHealthcare● Active
$28.29
$-0.50(-1.74%)
Market Cap$1.7B
P/E Ratio
52W High$46
52W Low$22.24
Overview

Agios Pharmaceuticals, Inc. (AGIO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AGIO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-7.25agio eps ttm · agio earnings per shareEarnings history
PE Ratio (TTM)agio pe ratio ttm · agio price to earningsPE Ratio deep dive
Revenue (TTM)$66.0Magio revenue ttm · agio annual revenueFull revenue history
Dividend YieldNo Dividenddoes agio pay dividends · agio dividend yieldDividend history
Shares Outstanding58.0Magio shares outstanding · agio floatShares outstanding history
Next EarningsJul 30, 2026Est.agio earnings date · agio next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$54.0M▲ +48.03% YoY
202320242025
agios pharmaceuticals, inc. revenue · agio revenue 2025
FY 2025Net Income-$412.8M▼ 161.27% YoY
202320242025
agios pharmaceuticals, inc. net income · agio profit 2025
FY 2025EPS$-7.12▼ 160.03% YoY
202320242025
agio eps · agios pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $66.0MNet Income: -$422.6MEPS: $-7.25View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy29 analystsis agio a buy · agio analyst rating
Strong Buy
0
Buy
22
Hold
7
Sell
0
Strong Sell
0
12-Month Price Target
$36.00Low
$28.29Current
$42.00Avg Target48.46% upside
$50.00High
agio price target · agio 12 month forecast

Total: 29 · Buy rate: 75.9%

The AGIO analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $42.00, representing +48.46% upside from the current price of $28.29.

Stock Performance

Full History
1D-1.74%
1W+6.71%
1M+1.80%
3M+2.99%
YTD+3.93%
1Y-15.95%
5Y-52.83%

About Agios Pharmaceuticals, Inc.

CEOBrian Goff
IPO DateJul 24, 2013
Employees486
CountryUS
Websiteagios.com

Agios Pharmaceuticals, Inc. a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PY…

what is agios pharmaceuticals, inc. · agio stock overview · agios pharmaceuticals, inc. company profile · who is agios pharmaceuticals, inc. ceo · agio NASDAQ · agios pharmaceuticals, inc. headquarters · agios pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Agios Pharmaceuticals, Inc. (AGIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 2013. As of the latest trading session, AGIO stock price is $28.29, with a market capitalization of $1.7B. The stock has returned -15.95% over the past 12 months and +3.93% year-to-date.

According to 29 Wall Street analysts, the consensus rating for Agios Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $42.00. In fiscal year 2025, Agios Pharmaceuticals, Inc. reported revenue of $54.0M and net income of -$412.8M. For detailed data — including Agios Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Agios Pharmaceuticals, Inc. (AGIO) stock price is $28.29. The stock is traded on NASDAQ under the ticker symbol AGIO. The 52-week range is $22.24 – $46.00.

AGIO stock priceAGIO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice